Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FT1W6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,332
Award facts
- Contract value 100% obligated
- $8,331.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,331.72 delivery order to DMS Pharmaceutical Group Inc. for 68 mg Nexplanon implants, a contraceptive device used in military and federal healthcare facilities. This delivery order, issued on May 6, 2025, with an ultimate completion date of May 28, 2025, operates under a firm fixed-price structure with no set-aside designation. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare sites worldwide.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has established itself as a key supplier within the federal pharmaceutical supply chain. The company specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military and federal healthcare facilities. Through its substantial IDC with DLA under the SPE2DB program, the company maintains a robust portfolio of pharmaceutical product deliveries spanning contraceptive devices, oncology treatments, vaccines, and specialty medications, positioning it as a critical distributor supporting the medical supply needs of the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FT1W6?
SPE2DB25FT1W6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 6, 2025.
How much is contract SPE2DB25FT1W6 worth?
The government has obligated $8,332 on SPE2DB25FT1W6.
Is contract SPE2DB25FT1W6 an order under another contract?
Yes. SPE2DB25FT1W6 is a delivery order under SPE2DB20D9371, an indefinite delivery contract.
Was contract SPE2DB25FT1W6 competed?
The extent of competition for SPE2DB25FT1W6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award